Cipla Limited
Overview
Cipla Limited is a global pharmaceutical company based in India focused on developing, manufacturing, and distributing a wide range of medications. The company specializes in therapies for various medical conditions, ensuring access to affordable medicines for patients worldwide.
Core services & business areas
Therapeutic areas
Active pharmaceutical ingredients supplied
Substances Cipla Limited is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
FDA compliance signals
3 FDA enforcement records linked to this company.
- recall — Class II2026-07-08
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
- recall — Class II2026-07-08
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
- recall — Class II2026-07-08
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Is this Cipla Limited? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.